(17beta)-N-(2-Methyl-2-propanyl)-3-oxoandrost-4-ene-17-carboxamide(CAS: 131267-80-6)

Regulatory guidelines for (17beta)-N-(2-Methyl-2-propanyl)-3-oxoandrost-4-ene-17-carboxamide (CAS: 131267-80-6) include classification under the Globally Harmonized System of Classification and Labelling of Chemicals (GHS), requirements under the Registration, Evaluation, Authorization and Restriction of Chemicals (REACH) in Europe, and regulations by the Food and Drug Administration (FDA) and Environmental Protection Agency (EPA) in the United States. Proper handling and disposal as per these guidelines are essential for safe use and management.

Alternatives to (17beta)-N-(2-Methyl-2-propanyl)-3-oxoandrost-4-ene-17-carboxamide in synthesis include other androstane derivatives, such as 17α-androst-4-ene-3,17-dione or 17β-androst-4-ene-3,17-dione. These can serve as effective substitutes due to their similar structural and functional properties. Careful selection based on the specific application is recommended.

The market and research trends for (17beta)-N-(2-Methyl-2-propanyl)-3-oxoandrost-4-ene-17-carboxamide (CAS: 131267-80-6) indicate increasing interest in its use as a precursor in steroid chemistry and medicinal research. There are ongoing developments in its application for hormone therapy and drug development. The trend suggests a growing focus on understanding its biological activity and potential therapeutic uses.

Waste containing (17beta)-N-(2-Methyl-2-propanyl)-3-oxoandrost-4-ene-17-carboxamide (CAS: 131267-80-6) should be collected in appropriate containers and handled according to local regulations. Proper incineration or professional waste disposal services should be employed. Environmental protection measures, such as neutralization of acids or bases and ensuring no hazardous emissions, are crucial to prevent environmental contamination.